Data-Driven Decision Making

The ad-tech giant posted record revenue for 2025, but a weaker-than-expected forecast for early 2026 sent its stock tumbling. What's next?

IMO Health integrates a global rare disease database into EHRs, promising to shorten diagnosis times and accelerate vital research for millions.

The sports betting aggregator launches AtlasDFS, an integrated Pick'em game, aiming to become an all-in-one hub for fans amid fierce regulatory headwinds.

A new partnership adds 500M+ government-sourced locations to an open map project, aiming to revolutionize AI, analytics, and the geospatial industry.

Hawaiian beverage company Waiākea rolls out the world's first carbon-negative algae ink on its bottles, an open-source move to transform the industry.

P4ML joins the Orphan Therapeutics Accelerator to bring shelved cures to patients, leveraging a new non-profit model and expanding access to the MENA region.

Plus Therapeutics' REYOBIQ gains a crucial CPT code, a vital step in bringing this targeted radiotherapy to patients with aggressive brain cancers.

Medtech giant reveals its 'Magnificent Seven' innovations and new data, with Chief Movement Officer Arnold Schwarzenegger leading the charge at AAOS 2026.

With an $11.75M boost, a new device promises blood results in minutes, not hours, signaling a major pharma player's strategic pivot into diagnostics.

With the appointment of TechTarget co-founder Don Hawk, Life Science Connect is set to import a proven B2B intent data playbook into the life sciences.

With its transformative Lanteris acquisition complete, all eyes are on Intuitive Machines' upcoming financial results for clues to its future as a space prime.

New FDA-cleared Persona PLUS technology promises to increase plasma yields per donor, tackling the growing global demand for life-saving therapies.

A newly identified blood biomarker for the drug masitinib could revolutionize how doctors treat ALS, progressive MS, and Alzheimer's disease.

The $20B wealth firm appoints a veteran partner as its first CEO, signaling a new era of strategic growth while doubling down on its core values.

Dupixent's landmark FDA approval offers a new, surgery-sparing option for a debilitating sinus disease, but questions of access and cost remain.

As political ad spend shifts to streaming, AdImpact launches AdMo+, a new tool designed to give campaigns a critical edge in the evolving media landscape.

The Raine Group hires Credit Suisse veteran Anthony Kontoleon, signaling a major push to dominate TMT advisory ahead of an anticipated tech boom.

With $14.2M in new funding, Handl Health is using AI and data to dismantle one-size-fits-all insurance, promising lower costs and better care.

Amid fluctuating NCLEX pass rates, UWorld launches an intensive three-day review designed to boost student success and ease the burden on nursing faculty.

A new partnership moves past simple endorsements, offering Baylor athletes internships and career skills, setting a new standard for corporate NIL deals.